Head-to-head · WeighScore
No BS RX vs Velvet Rx
The verdict
No BS RX takes it — 82.8/100 to 58.1/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | No BS RX | Velvet Rx |
|---|---|---|
| WeighScore | 82.8/100 | 58.1/100 |
| Grade | B− | C |
| Site position | #25 | #429 |
| Semaglutide | $179/mo month-to-month (a separate low-dose program is $140) | $99 advertised starting offer (renewal unverified) |
| Tirzepatide | $249/mo month-to-month (a separate low-dose program is $140) | $179 advertised starting offer (renewal unverified) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #25 · B−
Strengths
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
- Six programs across four terms are published with no intake and no account
- A sleep program is priced on the same page, including a diagnostic ring study at $33/mo
Where it loses points
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company
- State availability is not published, and there is no FDA-approved brand lane
Site position #429 · C
Strengths
- Advertises $99 semaglutide, $179 tirzepatide and $149 oral GLP-1 offers
- Terms identify Rocket Health Inc and provide an Oceanside, California address
- Names RedRock, Health Warehouse, Precision Compounding Pharmacy and Triad Rx in its pharmacy network
- Lists injectable and oral treatment options
Where it loses points
- Introductory amounts do not establish the ongoing charge or billing interval
- The selected formulation and product-to-pharmacy assignment remain unconfirmed
- State-specific product availability must be confirmed; a licensing statement is not a nationwide shipping guarantee
- Processed or discounted orders may be nonrefundable under the published terms
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.